Directory

>

Michael Metzger

avatar

Michael Metzger

Member Board of Directors | Pyxis Oncology

New York, New York, United States

View contact details (it's free)

Michael Metzger

Summary

Michael Metzger is a seasoned executive in the biotechnology sector, currently serving as the CEO of Syndax Pharmaceuticals, where he is instrumental in developing targeted cancer therapies. With a robust background that spans from managing startups to steering companies through IPOs, he has a proven ability to enhance company value through strategic financial maneuvers and team development. His leadership experience includes significant roles on boards of various biopharmaceutical firms, reflecting his deep commitment to the life sciences industry. Michael's expertise encompasses a range of areas, including business development, mergers and acquisitions, and venture capital. He holds an MBA in Finance from NYU Stern and a BA in Political Science from The George Washington University, equipping him with a strong analytical foundation. His career trajectory demonstrates a consistent focus on innovation and transformative therapies, highlighting his dedication to advancing healthcare solutions. Beyond his professional pursuits, Michael is known for his strategic thinking and ability to adapt to the evolving landscape of biotechnology.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Industry-specific interests

Emerging Technologies

Leadership Development

Organisational experience

Startup Experience

Corporate Experience

Consulting Experience

Michael Metzger

Work Experience

company logo

Member Board of Directors at

Pyxis Oncology

June 2024 - Present

company logo

Chief Executive Officer and Director at

Syndax Pharmaceuticals

February 2022 - Present

company logo

Member Board of Directors at

CTI BioPharma

January 2017 - July 2023

company logo

Member Board of Directors at

Tarveda Therapeutics

June 2017 - April 2022

company logo

President, Chief Operating Officer and Director at

Syndax Pharmaceuticals

May 2015 - January 2022

company logo

President and Chief Operating Officer at

Regado BioSciences, Inc.

December 2013 - April 2015

company logo

President and Chief Executive Officer at

Regado BioSciences, Inc.

October 2014 - April 2015

company logo

Executive Vice President and Chief Operating Officer at

Mersana Therapeutics

March 2011 - November 2013

company logo

Member Board of Directors at

Response Genetics

November 2010 - November 2013

company logo

Senior Director Business Development at

Forest Laboratories (now Allergan)

September 2006 - March 2011

company logo

VP Corporate Development at

Onconova Therapeutics

September 2001 - September 2006

company logo

Managing Director at

Mesa Partners

January 1997 - August 2001

company logo

Manager at

Oxford Health Plans

January 1995 - January 1997

Logos provided by Logo.dev

Michael Metzger

Education

New York University Stern School of Business, Mba

January 2001 - January 2003

The George Washington University, B.A.

January 1989 - January 1993

Frequently Asked Questions about Michael Metzger

What is Michael Metzger email address?

Michael Metzger's primary email address is ********@syndax.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Michael Metzger work for?

Michael Metzger is a Member Board of Directors at Pyxis Oncology, a company specializing in Pharmaceutical preparations.

Where Michael Metzger graduated from?

Michael Metzger holds a degree in Finance from New York University Stern School of Business.

How can I directly contact Michael Metzger?

To contact Michael Metzger directly, you can use the email address ********@syndax.com. Complete contact information is available upon registration with Muraena.

Who is Michael Metzger?

Michael Metzger is a seasoned executive in the biotechnology sector, currently serving as the CEO of Syndax Pharmaceuticals, where he is instrumental in developing targeted cancer therapies. With a robust background that spans from managing startups to steering companies through IPOs, he has a proven ability to enhance company value through strategic financial maneuvers and team development. His leadership experience includes significant roles on boards of various biopharmaceutical firms, reflecting his deep commitment to the life sciences industry. Michael's expertise encompasses a range of areas, including business development, mergers and acquisitions, and venture capital. He holds an MBA in Finance from NYU Stern and a BA in Political Science from The George Washington University, equipping him with a strong analytical foundation. His career trajectory demonstrates a consistent focus on innovation and transformative therapies, highlighting his dedication to advancing healthcare solutions. Beyond his professional pursuits, Michael is known for his strategic thinking and ability to adapt to the evolving landscape of biotechnology.

Michael`s contact details

mail

********@syndax.com

**@ctibiopharma.com

Colleagues

avatar
Stan Szpindor

Vice President, R&D Quality

avatar
Supriya Roth

Vice President of Commercial Development

avatar
Lara Sullivan

President & Chief Executive Officer

Darren Cline

Chief Commercial Officer

avatar
Tom Dorney

VP, Strategy & Financial Planning

avatar
Jan Pinkas

Chief Scientific Officer

avatar
Jitu Wadhane

SVP Finance and Chief Accounting Officer

View Contact details (it's free)
Request Profile Removal